Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt No Debt
CUTR's Cash-to-Debt is ranked higher than
98% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. CUTR: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
CUTR' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.66
CUTR's Equity-to-Asset is ranked higher than
57% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. CUTR: 0.66 )
Ranked among companies with meaningful Equity-to-Asset only.
CUTR' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.27  Med: 0.79 Max: 0.87
Current: 0.66
-0.27
0.87
Interest Coverage No Debt
CUTR's Interest Coverage is ranked higher than
97% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: 93.54 vs. CUTR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
CUTR' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 8
Altman Z-Score: 7.25
Beneish M-Score: -2.13
WACC vs ROIC
4.48%
45.51%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 2.03
CUTR's Operating Margin % is ranked lower than
52% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. CUTR: 2.03 )
Ranked among companies with meaningful Operating Margin % only.
CUTR' s Operating Margin % Range Over the Past 10 Years
Min: -20.83  Med: -7.94 Max: 9.39
Current: 2.03
-20.83
9.39
Net Margin % 2.18
CUTR's Net Margin % is ranked higher than
51% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. CUTR: 2.18 )
Ranked among companies with meaningful Net Margin % only.
CUTR' s Net Margin % Range Over the Past 10 Years
Min: -32.93  Med: -7.42 Max: 10.33
Current: 2.18
-32.93
10.33
ROE % 4.93
CUTR's ROE % is ranked higher than
58% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. CUTR: 4.93 )
Ranked among companies with meaningful ROE % only.
CUTR' s ROE % Range Over the Past 10 Years
Min: -16.6  Med: -6.99 Max: 9.59
Current: 4.93
-16.6
9.59
ROA % 3.22
CUTR's ROA % is ranked higher than
63% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. CUTR: 3.22 )
Ranked among companies with meaningful ROA % only.
CUTR' s ROA % Range Over the Past 10 Years
Min: -13.66  Med: -5.3 Max: 7.71
Current: 3.22
-13.66
7.71
ROC (Joel Greenblatt) % 45.21
CUTR's ROC (Joel Greenblatt) % is ranked higher than
84% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 4.02 vs. CUTR: 45.21 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CUTR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1247.08  Med: -223.26 Max: 140.19
Current: 45.21
-1247.08
140.19
3-Year Revenue Growth Rate 18.40
CUTR's 3-Year Revenue Growth Rate is ranked higher than
86% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. CUTR: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CUTR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -18.1  Med: 10.1 Max: 54.9
Current: 18.4
-18.1
54.9
GuruFocus has detected 4 Warning Signs with Cutera Inc $CUTR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CUTR's 10-Y Financials

Financials (Next Earnings Date: 2017-05-13 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

CUTR Guru Trades in Q1 2016

Jim Simons 1,074,900 sh (+8.16%)
Mario Gabelli 605,000 sh (unchged)
» More
Q2 2016

CUTR Guru Trades in Q2 2016

Mario Gabelli 605,000 sh (unchged)
Jim Simons 1,025,800 sh (-4.57%)
» More
Q3 2016

CUTR Guru Trades in Q3 2016

Jim Simons 1,045,400 sh (+1.91%)
Discovery Group I, LLC 97,194 sh (unchged)
Mario Gabelli 605,000 sh (unchged)
» More
Q4 2016

CUTR Guru Trades in Q4 2016

Discovery Group I, LLC 212,139 sh (+118.26%)
Jim Simons 1,063,260 sh (+1.71%)
Mario Gabelli 605,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:TCMD, NAS:VRAY, NAS:AXGN, NAS:RTIX, NAS:ELOS, OTCPK:IPDQF, NAS:EXAC, NAS:OBLN, AMEX:CVRS, NYSE:IVC, NAS:IRIX, NAS:PAVM, NAS:ARAY, NAS:NVCN, NAS:ACRX, NAS:CGNT, NAS:FONR, NAS:DRAD, NAS:MSON, NAS:XENT » details
Traded in other countries:TJ9.Germany,
Cutera Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners.

Cutera Inc was established in the San Francisco Bay Area in 1998. It is a medical device company, specializing in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. It offers easy-to-use products based on four main platforms/systems Xeo, GenesisPlus, ExcelV, and truSculpt, each of which enables physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. The Xeo is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. GenesisPlus platform, is a dedicated laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis, or toenail fungus. ExcelV is a high-performance, vascular platform designed specifically for the core-market of Dermatologists and Plastic Surgeons. This platform provides a combination of the 532 nm green laser with Cutera's award-winning 1064 nm Nd:YAG technology, to provide a single, compact and efficient system that treats the entire range of cosmetic vascular conditions, without the need for costly consumables. truSculpt is a high-powered radio frequency platform designed for the non-invasive body contouring market. This system is designed to treat all body areas and with its electrode design is able to achieve comfortable, uniform heating of the subcutaneous fat. In the U.S. its markets and sells its products mainly through a direct sales organization. International sales are generally made through a distributor network in over 60 countries. As of December 31, 2013, the Company had 30 issued U.S. patents and 11 pending U.S. patent applications. Its registered trademarks include Cutera, Acutip 500, CoolGlide, CoolGlide Excel, Limelight, myQ, Pearl, ProWave 770, ProWave LX, Solera, Titan, Xeo and truSculpt. The Company's products competes against laser and other energy-based products offered by public companies, such as Cynosure, Elen (in Italy), Lumenis, Syneron and Zeltiq, as well as private companies, including, Alma, Sciton, and several others. Its products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, as well as other regulatory bodies.

Ratios

vs
industry
vs
history
PE Ratio 112.81
CUTR's PE Ratio is ranked lower than
91% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 27.89 vs. CUTR: 112.81 )
Ranked among companies with meaningful PE Ratio only.
CUTR' s PE Ratio Range Over the Past 10 Years
Min: 14.53  Med: 27.11 Max: 639
Current: 112.81
14.53
639
Forward PE Ratio 44.44
CUTR's Forward PE Ratio is ranked lower than
86% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 23.04 vs. CUTR: 44.44 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 112.81
CUTR's PE Ratio without NRI is ranked lower than
92% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. CUTR: 112.81 )
Ranked among companies with meaningful PE Ratio without NRI only.
CUTR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.53  Med: 27.11 Max: 639
Current: 112.81
14.53
639
PB Ratio 4.49
CUTR's PB Ratio is ranked lower than
63% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.35 vs. CUTR: 4.49 )
Ranked among companies with meaningful PB Ratio only.
CUTR' s PB Ratio Range Over the Past 10 Years
Min: 0.68  Med: 1.58 Max: 4.6
Current: 4.49
0.68
4.6
PS Ratio 2.30
CUTR's PS Ratio is ranked higher than
62% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.31 vs. CUTR: 2.30 )
Ranked among companies with meaningful PS Ratio only.
CUTR' s PS Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.95 Max: 5.16
Current: 2.3
0.93
5.16
Price-to-Free-Cash-Flow 228.07
CUTR's Price-to-Free-Cash-Flow is ranked lower than
93% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 29.73 vs. CUTR: 228.07 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CUTR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.45  Med: 46.72 Max: 831.43
Current: 228.07
8.45
831.43
Price-to-Operating-Cash-Flow 157.37
CUTR's Price-to-Operating-Cash-Flow is ranked lower than
99% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. CUTR: 157.37 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CUTR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.11  Med: 39.16 Max: 633
Current: 157.37
8.11
633
EV-to-EBIT 92.93
CUTR's EV-to-EBIT is ranked lower than
95% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 23.96 vs. CUTR: 92.93 )
Ranked among companies with meaningful EV-to-EBIT only.
CUTR' s EV-to-EBIT Range Over the Past 10 Years
Min: -3233.4  Med: -3.8 Max: 695.7
Current: 92.93
-3233.4
695.7
EV-to-EBITDA 65.92
CUTR's EV-to-EBITDA is ranked lower than
88% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 17.54 vs. CUTR: 65.92 )
Ranked among companies with meaningful EV-to-EBITDA only.
CUTR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -503.2  Med: -3.5 Max: 172.5
Current: 65.92
-503.2
172.5
Current Ratio 3.09
CUTR's Current Ratio is ranked higher than
64% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. CUTR: 3.09 )
Ranked among companies with meaningful Current Ratio only.
CUTR' s Current Ratio Range Over the Past 10 Years
Min: 2.62  Med: 6.11 Max: 9.09
Current: 3.09
2.62
9.09
Quick Ratio 2.57
CUTR's Quick Ratio is ranked higher than
66% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. CUTR: 2.57 )
Ranked among companies with meaningful Quick Ratio only.
CUTR' s Quick Ratio Range Over the Past 10 Years
Min: 2.37  Med: 5.6 Max: 8.66
Current: 2.57
2.37
8.66
Days Inventory 104.86
CUTR's Days Inventory is ranked higher than
61% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 125.58 vs. CUTR: 104.86 )
Ranked among companies with meaningful Days Inventory only.
CUTR' s Days Inventory Range Over the Past 10 Years
Min: 66.49  Med: 104.48 Max: 137.01
Current: 104.86
66.49
137.01
Days Sales Outstanding 51.16
CUTR's Days Sales Outstanding is ranked higher than
73% of the 240 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. CUTR: 51.16 )
Ranked among companies with meaningful Days Sales Outstanding only.
CUTR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.62  Med: 40.06 Max: 52.02
Current: 51.16
22.62
52.02
Days Payable 19.00
CUTR's Days Payable is ranked lower than
87% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. CUTR: 19.00 )
Ranked among companies with meaningful Days Payable only.
CUTR' s Days Payable Range Over the Past 10 Years
Min: 17.66  Med: 20.42 Max: 36.15
Current: 19
17.66
36.15

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 1.30
CUTR's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. CUTR: 1.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CUTR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.6  Med: -2.45 Max: 3
Current: 1.3
-13.6
3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 11.73
CUTR's Price-to-Net-Cash is ranked higher than
56% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 15.26 vs. CUTR: 11.73 )
Ranked among companies with meaningful Price-to-Net-Cash only.
CUTR' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.44  Med: 2.53 Max: 11.99
Current: 11.73
1.44
11.99
Price-to-Net-Current-Asset-Value 4.78
CUTR's Price-to-Net-Current-Asset-Value is ranked higher than
65% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. CUTR: 4.78 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
CUTR' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.2  Med: 2.02 Max: 4.88
Current: 4.78
1.2
4.88
Price-to-Tangible-Book 4.56
CUTR's Price-to-Tangible-Book is ranked lower than
51% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 4.19 vs. CUTR: 4.56 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CUTR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.02  Med: 1.85 Max: 4.66
Current: 4.56
1.02
4.66
Price-to-Intrinsic-Value-Projected-FCF 11.53
CUTR's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
93% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. CUTR: 11.53 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CUTR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.62  Med: 1.36 Max: 11.79
Current: 11.53
0.62
11.79
Price-to-Median-PS-Value 1.18
CUTR's Price-to-Median-PS-Value is ranked lower than
60% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 1.07 vs. CUTR: 1.18 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CUTR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.71  Med: 1.02 Max: 2.46
Current: 1.18
0.71
2.46
Price-to-Graham-Number 4.78
CUTR's Price-to-Graham-Number is ranked lower than
75% of the 131 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. CUTR: 4.78 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CUTR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.32  Med: 1.94 Max: 5.08
Current: 4.78
1.32
5.08
Earnings Yield (Greenblatt) % 1.09
CUTR's Earnings Yield (Greenblatt) % is ranked higher than
56% of the 339 Companies
in the Global Medical Devices industry.

( Industry Median: -0.81 vs. CUTR: 1.09 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CUTR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 7.7 Max: 795.7
Current: 1.09
0.1
795.7

More Statistics

Revenue (TTM) (Mil) $118.1
EPS (TTM) $ 0.18
Beta0.26
Short Percentage of Float1.13%
52-Week Range $9.83 - 22.96
Shares Outstanding (Mil)13.87

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 138 158 182
EPS ($) 0.45 0.65 0.90
EPS without NRI ($) 0.45 0.65 0.90
EPS Growth Rate
(Future 3Y To 5Y Estimate)
33.00%
Dividends per Share ($)
» More Articles for CUTR

Headlines

Articles On GuruFocus.com
Chuck Royce's Top Five Second Quarter Portfolio Increases Aug 07 2013 
Gurus Buy Micro Caps – Bamboo Toilet Paper Jul 24 2013 
Guru Weekly Real Time Update Jul 05 2013 
Mario Gabelli and Jean-Marie Eveillard's Real Time Increases Jul 02 2013 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 

More From Other Websites
CUTERA INC Financials Mar 21 2017
Cutera, Inc. :CUTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
CUTERA INC Files SEC form 10-K, Annual Report Mar 15 2017
Cutera to Present at the Sidoti & Company Spring 2017 Convention Mar 09 2017
Cutera to Present at the 29th Annual ROTH Conference Feb 28 2017
Why Cutera (CUTR) Stock Might be a Great Pick Feb 17 2017
Cutera, Inc. :CUTR-US: Earnings Analysis: 2016 By the Numbers : February 15, 2017 Feb 15 2017
Edited Transcript of CUTR earnings conference call or presentation 13-Feb-17 10:00pm GMT Feb 14 2017
Cutera posts 4Q profit Feb 13 2017
Cutera posts 4Q profit Feb 13 2017
CUTERA INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Feb 13 2017
Cutera Reports Fourth Quarter and Full-Year 2016 Record Revenue and Financial Results Feb 13 2017
Q4 2016 Cutera Inc Earnings Release - After Market Close Feb 13 2017
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2016 Results Jan 30 2017
CUTERA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and... Jan 11 2017
Cutera (CUTR) Worth Watching: Stock Adds 6.1% in Session Jan 11 2017
Cutera Names James A. Reinstein as its Next President and CEO Jan 09 2017
Cutera Announces Record Revenue and Preliminary Financial Results for Fourth Quarter and Full Year... Jan 09 2017
8 Stocks with Recent Price Strength to Boost Your Portfolio Dec 30 2016
Stay Ahead of Time: Buy 8 Stocks with Recent Price Strength Dec 14 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)